Atıf Formatları
The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

I. Yonal-Hindilerden Et Al. , "The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020

Yonal-Hindilerden, I. Et Al. 2020. The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20 .

Yonal-Hindilerden, I., Sahin, E., Hindilerden, F., Daglar-Aday, A., & Nalcaci, M., (2020). The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20.

Yonal-Hindilerden, İpek Et Al. "The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020

Yonal-Hindilerden, İpek Y. Et Al. "The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, 2020

Yonal-Hindilerden, I. Et Al. (2020) . "The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20.

@article{article, author={İpek YÖNAL HİNDİLERDEN Et Al. }, title={The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2020}